Published in Exp Diabetes Res on November 24, 2011
Cardiovascular Risk in Infants Exposed to Pre-eclampsia in Utero | NCT05091827
Insulin-increased L-arginine transport requires A(2A) adenosine receptors activation in human umbilical vein endothelium. PLoS One (2012) 0.91
Modulation of endothelial cell migration by ER stress and insulin resistance: a role during maternal obesity? Front Pharmacol (2014) 0.83
Inflammation and impaired endothelium-dependant vasodilatation in non obese women with gestational diabetes mellitus: preliminary results. Lipids Health Dis (2013) 0.82
Increased endothelial inflammation, sTie-2 and arginase activity in umbilical cords obtained from gestational diabetic mothers. PLoS One (2013) 0.82
Role for Tetrahydrobiopterin in the Fetoplacental Endothelial Dysfunction in Maternal Supraphysiological Hypercholesterolemia. Oxid Med Cell Longev (2015) 0.75
Diseases of pregnancy and fetal programming: cell and molecular mechanisms. Biomed Res Int (2014) 0.75
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA (2004) 25.36
Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med (2005) 16.55
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA (2001) 15.85
Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care (2001) 14.03
Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol (2006) 10.05
Progress and challenges in translating the biology of atherosclerosis. Nature (2011) 9.41
Diagnosis and classification of diabetes mellitus. Diabetes Care (2011) 9.37
Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics (2005) 8.99
Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol (2005) 8.39
Obesity, inflammation, and insulin resistance. Gastroenterology (2007) 7.54
Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol (2004) 6.78
Role of endothelial dysfunction in atherosclerosis. Circulation (2004) 5.77
Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab (2001) 5.76
Gestational weight gain and child adiposity at age 3 years. Am J Obstet Gynecol (2007) 5.65
The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol (2010) 5.54
Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation (2000) 5.53
Fetal origins of obesity. Obes Res (2003) 5.48
Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care (2007) 5.41
Association of maternal weight gain in pregnancy with offspring obesity and metabolic and vascular traits in childhood. Circulation (2010) 4.12
Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation (1996) 3.40
Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet (1999) 3.34
Maternal gestational diabetes, birth weight, and adolescent obesity. Pediatrics (2003) 3.27
Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care (2007) 3.27
High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care (2007) 3.13
Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care (2009) 3.05
Fetal programming of coronary heart disease. Trends Endocrinol Metab (2002) 3.00
The equilibrative nucleoside transporter family, SLC29. Pflugers Arch (2003) 3.00
Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res (2007) 2.96
Maternal gestational weight gain and offspring weight in adolescence. Obstet Gynecol (2008) 2.90
Predicting obesity in early adulthood from childhood and parental obesity. Int J Obes Relat Metab Disord (2003) 2.88
Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol (2008) 2.75
Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circ Res (2008) 2.70
The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol (2006) 2.70
Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest (1990) 2.69
CATs and HATs: the SLC7 family of amino acid transporters. Pflugers Arch (2003) 2.69
Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta (2008) 2.67
Increased neonatal fat mass, not lean body mass, is associated with maternal obesity. Am J Obstet Gynecol (2006) 2.63
Gestational weight gain and risk of overweight in the offspring at age 7 y in a multicenter, multiethnic cohort study. Am J Clin Nutr (2008) 2.58
Increasing prevalence of Type II diabetes in American Indian children. Diabetologia (1998) 2.57
Associations of gestational weight gain with offspring body mass index and blood pressure at 21 years of age: evidence from a birth cohort study. Circulation (2009) 2.56
The predisposition to obesity and diabetes in offspring of diabetic mothers. Diabetes Care (2007) 2.53
Intrauterine exposure to gestational diabetes, child adiposity, and blood pressure. Am J Hypertens (2008) 2.50
Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr (2000) 2.44
Oxidized low-density lipoprotein-dependent endothelial arginase II activation contributes to impaired nitric oxide signaling. Circ Res (2006) 2.42
Recent advances in arginine metabolism: roles and regulation of the arginases. Br J Pharmacol (2009) 2.24
Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Ann Med (2008) 2.23
Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care (2008) 2.22
Overweight and the metabolic syndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes. J Clin Endocrinol Metab (2009) 2.15
Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab (1998) 2.12
Maternal C-reactive protein and developmental programming of atherosclerosis. Am J Obstet Gynecol (2008) 2.11
Parental overweight, socioeconomic status and high birth weight are the major determinants of overweight and obesity in 5-7 y-old children: baseline data of the Kiel Obesity Prevention Study (KOPS). Int J Obes Relat Metab Disord (2004) 2.08
Adenosine: an old drug newly discovered. Anesthesiology (2009) 1.99
Long-term effects of the intrauterine environment, birth weight, and breast-feeding in Pima Indians. Diabetes Care (1998) 1.98
Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab (2006) 1.97
Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol (2004) 1.97
Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol (2011) 1.95
Obesity and pregnancy--the propagation of a viscous cycle? J Clin Endocrinol Metab (2003) 1.90
Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res (2001) 1.89
Identification and characterization of a novel monoamine transporter in the human brain. J Biol Chem (2004) 1.88
Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol Rev (1998) 1.86
The influence of birthweight and intrauterine environment on adiposity and fat distribution in later life. Int J Obes Relat Metab Disord (2003) 1.84
Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J Clin Invest (2002) 1.80
Human primary adipocytes exhibit immune cell function: adipocytes prime inflammation independent of macrophages. PLoS One (2011) 1.77
The fetal and maternal consequences of gestational diabetes mellitus. J Matern Fetal Neonatal Med (2010) 1.76
Human endothelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1. Circ Res (2009) 1.74
Gestational weight gain in relation to offspring body mass index and obesity from infancy through adulthood. Int J Obes (Lond) (2009) 1.72
Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem (1995) 1.71
Obesity, gestational diabetes and pregnancy outcome. Semin Fetal Neonatal Med (2008) 1.71
Effect of treatment of gestational diabetes mellitus on obesity in the next generation. Diabetes Care (2010) 1.68
Equilibrative nucleoside transporter 1 expression is downregulated by hypoxia in human umbilical vein endothelium. Circ Res (2005) 1.68
The effects of plasma insulin and glucose on myocardial blood flow in patients with type 1 diabetes mellitus. J Am Coll Cardiol (2005) 1.66
Infants of diabetic mothers. Pediatr Clin North Am (2004) 1.66
Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH. Circ Res (2006) 1.63
Effect of diabetes in pregnancy on offspring: follow-up research in the Pima Indians. J Matern Fetal Med (2000) 1.63
The influence of obesity and diabetes on the risk of cesarean delivery. Am J Obstet Gynecol (2004) 1.58
Dynamics of early childhood overweight. Pediatrics (2005) 1.58
Nitric oxide reduces SLC29A1 promoter activity and adenosine transport involving transcription factor complex hCHOP-C/EBPalpha in human umbilical vein endothelial cells from gestational diabetes. Cardiovasc Res (2009) 1.58
Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev (2003) 1.57
The known and unknown of leptin in pregnancy. Am J Obstet Gynecol (2006) 1.57
Maternal serum triglyceride at 24--32 weeks' gestation and newborn weight in nondiabetic women with positive diabetic screens. Obstet Gynecol (2001) 1.55
The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care (2007) 1.54
Developmental origins of obesity and the metabolic syndrome: the role of maternal obesity. Front Horm Res (2008) 1.53
Review: Reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta (2010) 1.48
Endothelial dysfunction as a potential contributor in diabetic nephropathy. Nat Rev Nephrol (2010) 1.43
Gestational diabetes mellitus -- time to treat. N Engl J Med (2005) 1.43
Lipid parameters for measuring risk of cardiovascular disease. Nat Rev Cardiol (2011) 1.43
Maternal nutritional status in pregnancy and blood pressure in childhood. Br J Obstet Gynaecol (1994) 1.42
The developmental origins, mechanisms, and implications of metabolic syndrome. J Nutr (2010) 1.41
Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters. Mol Pharmacol (2000) 1.39
Placental structure and inflammation in pregnancies associated with obesity. Placenta (2011) 1.39
Review: The placenta is a programming agent for cardiovascular disease. Placenta (2010) 1.39
Size at birth, maternal nutritional status in pregnancy, and blood pressure at age 17: population based analysis. BMJ (1997) 1.37
Differential regulation of genes for fetoplacental lipid pathways in pregnancy with gestational and type 1 diabetes mellitus. Am J Obstet Gynecol (2009) 1.34
Maternal serum triglyceride, glucose tolerance, and neonatal birth weight ratio in pregnancy. Diabetes Care (1995) 1.33
Equilibrative nucleoside transporter 1 expression is downregulated by hypoxia in human umbilical vein endothelium. Circ Res (2005) 1.68
Nitric oxide reduces SLC29A1 promoter activity and adenosine transport involving transcription factor complex hCHOP-C/EBPalpha in human umbilical vein endothelial cells from gestational diabetes. Cardiovasc Res (2009) 1.58
Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev (2003) 1.57
Intervention strategies for preventing low birthweight in developing countries: importance of considering multiple interactive factors. Nestle Nutr Inst Workshop Ser (2013) 1.42
Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis. PLoS One (2013) 1.36
Early activation of the p42/p44MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism. FASEB J (2002) 1.13
Hypoxia-induced changes in the bioactivity of cytotrophoblast-derived exosomes. PLoS One (2013) 1.05
Mice long-term high-fat diet feeding recapitulates human cardiovascular alterations: an animal model to study the early phases of diabetic cardiomyopathy. PLoS One (2013) 1.01
Insulin restores gestational diabetes mellitus-reduced adenosine transport involving differential expression of insulin receptor isoforms in human umbilical vein endothelium. Diabetes (2011) 0.99
Insulin-stimulated L-arginine transport requires SLC7A1 gene expression and is associated with human umbilical vein relaxation. J Cell Physiol (2011) 0.95
Insulin-increased L-arginine transport requires A(2A) adenosine receptors activation in human umbilical vein endothelium. PLoS One (2012) 0.91
Gestational diabetes reduces adenosine transport in human placental microvascular endothelium, an effect reversed by insulin. PLoS One (2012) 0.91
Cell signalling-mediating insulin increase of mRNA expression for cationic amino acid transporters-1 and -2 and membrane hyperpolarization in human umbilical vein endothelial cells. Pflugers Arch (2004) 0.90
Epigenetics: new concepts of old phenomena in vascular physiology. Curr Vasc Pharmacol (2009) 0.89
Insulin restores glucose inhibition of adenosine transport by increasing the expression and activity of the equilibrative nucleoside transporter 2 in human umbilical vein endothelium. J Cell Physiol (2006) 0.89
Role of insulin and adenosine in the human placenta microvascular and macrovascular endothelial cell dysfunction in gestational diabetes mellitus. Microcirculation (2014) 0.88
Potential cell signalling mechanisms involved in differential placental angiogenesis in mild and severe pre-eclampsia. Curr Vasc Pharmacol (2009) 0.88
Rapid stimulation of L-arginine transport by D-glucose involves p42/44(mapk) and nitric oxide in human umbilical vein endothelium. Circ Res (2003) 0.87
5'-ectonucleotidase mediates multiple-drug resistance in glioblastoma multiforme cells. J Cell Physiol (2013) 0.86
Nitric oxide synthesis requires activity of the cationic and neutral amino acid transport system y+L in human umbilical vein endothelium. Exp Physiol (2003) 0.85
High D-glucose reduces SLC29A1 promoter activity and adenosine transport involving specific protein 1 in human umbilical vein endothelium. J Cell Physiol (2008) 0.85
Role of adenosine transport in gestational diabetes-induced L-arginine transport and nitric oxide synthesis in human umbilical vein endothelium. J Physiol (2004) 0.85
Inhibition of nitrobenzylthioinosine-sensitive adenosine transport by elevated D-glucose involves activation of P2Y2 purinoceptors in human umbilical vein endothelial cells. Circ Res (2002) 0.85
Hyperglycaemia inhibits thymidine incorporation and cell growth via protein kinase C, mitogen-activated protein kinases and nitric oxide in human umbilical vein endothelium. Exp Physiol (2003) 0.84
Maternal hypercholesterolemia in pregnancy associates with umbilical vein endothelial dysfunction: role of endothelial nitric oxide synthase and arginase II. Arterioscler Thromb Vasc Biol (2013) 0.82
Role of DNA methyltransferase 1 on the altered eNOS expression in human umbilical endothelium from intrauterine growth restricted fetuses. Epigenetics (2013) 0.82
[Normal plasma insulin and HOMA values among Chilean children and adolescents]. Rev Med Chil (2012) 0.82
Functional link between adenosine and insulin: a hypothesis for fetoplacental vascular endothelial dysfunction in gestational diabetes. Curr Vasc Pharmacol (2011) 0.82
Adenosine plasma levels in the fetoplacental circulation in preeclampsia. Am J Obstet Gynecol (2011) 0.82
Potential role of sodium-proton exchangers in the low concentration arsenic trioxide-increased intracellular pH and cell proliferation. PLoS One (2012) 0.81
Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human fetal endothelium from gestational diabetes. J Cell Physiol (2006) 0.81
Nitric Oxide is a Central Common Metabolite in Vascular Dysfunction Associated with Diseases of Human Pregnancy. Curr Vasc Pharmacol (2016) 0.81
Carbon monoxide: a novel pulmonary artery vasodilator in neonatal llamas of the Andean altiplano. Cardiovasc Res (2007) 0.80
[Subclinical atheroesclerosis and metabolic syndrome in children]. Nutr Hosp (2013) 0.80
D-glucose stimulation of L-arginine transport and nitric oxide synthesis results from activation of mitogen-activated protein kinases p42/44 and Smad2 requiring functional type II TGF-beta receptors in human umbilical vein endothelium. J Cell Physiol (2007) 0.80
TGF-beta1 inhibits expression and activity of hENT1 in a nitric oxide-dependent manner in human umbilical vein endothelium. Cardiovasc Res (2009) 0.80
Equilibrative nucleoside transporters in fetal endothelial dysfunction in diabetes mellitus and hyperglycaemia. Curr Vasc Pharmacol (2009) 0.80
Insulin therapy and fetoplacental vascular function in gestational diabetes mellitus. Exp Physiol (2015) 0.79
Increased expression of the multidrug resistance-associated protein 1 (MRP1) in kidney glomeruli of streptozotocin-induced diabetic rats. Biol Chem (2011) 0.78
A Hypothesis for the Role of RECK in Angiogenesis. Curr Vasc Pharmacol (2016) 0.77
Equilibrative nucleoside (ENTs) and cationic amino acid (CATs) transporters: implications in foetal endothelial dysfunction in human pregnancy diseases. Curr Vasc Pharmacol (2007) 0.77
Over-expression of muscle glycogen synthase in human diabetic nephropathy. Histochem Cell Biol (2014) 0.76
Do adenosine receptors offer new therapeutic options for diabetic nephropathy? Curr Vasc Pharmacol (2009) 0.75
Arginase-endothelial nitric oxide synthase imbalance contributes to endothelial dysfunction during chronic intermittent hypoxia. J Hypertens (2015) 0.75
[Combined influence of preconception body mass index and gestational weight gain on fetal growth]. Rev Med Chil (2011) 0.75
Control of the vasculature: pharmacological targets in vascular disease. Curr Vasc Pharmacol (2009) 0.75
[Blood lipids in Chilean children 10-14 years of age]. Nutr Hosp (2013) 0.75
[Association of carotid intima media thickness with blood pressure and HDL cholesterol in children]. Rev Med Chil (2012) 0.75